Koh Ono

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 33

Top Topics

Atrial Fibrillation

Percutaneous Coronary Intervention

Acute Myocardial Infarction

Direct Oral Anticoagulants

Top Venues

European heart journal. Cardiovascular pharmacotherapy

Journal of the American Heart Association

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hirotoshi Watanabe, Masahiro Natsuaki, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Tomoya Kimura, Kenji Ando, Takenori Domei, Satoru Suwa, Manabu Ogita, Tsuyoshi Isawa, Hiroyuki Takenaka, Takashi Yamamoto, Tetsuya Ishikawa, Itaru Hisauchi, Kohei Wakabayashi, Yuko Onishi, Kiyoshi Hibi, Kazuya Kawai, Ruka Yoshida, Hiroshi Suzuki, Gaku Nakazawa, Takanori Kusuyama, Itsuro Morishima, Koh Ono, Takeshi Kimura
Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial. European heart journal (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Shinya Ikeda, Yugo Yamashita, Koh Ono
Who Requires Longer-term Anticoagulation Therapy for Venous Thromboembolism from the Perspective of Precision Medicine? European heart journal. Cardiovascular pharmacotherapy (2024)
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui, Jiro Sakamoto, Yoshito Ogihara, Takeshi Inoue, Shunsuke Usami, Po-Min Chen, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Kosuke Doi, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Tomohiro Dohke, Ryusuke Nishikawa, Koh Ono, Takeshi Kimura
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era. Journal of the American Heart Association (2024)
Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Hideo Tokuyama, Hiroki Sakamoto, Takanari Fujita, Mamoru Nanasato, Hideki Okayama, Tenjin Nishikura, Hidekuni Kirigaya, Koji Nishida, Koh Ono, Takeshi Kimura
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial. European heart journal. Cardiovascular pharmacotherapy (2024)
Takahiro Horie, Koh Ono
VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. European heart journal. Cardiovascular pharmacotherapy 10 (2) (2024)
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Minoru Yamada, Tetsuzo Wakatsuki, Yoichi Nozaki, Hideki Kitahara, Ryuichi Kato, Ryoma Kawai, Yohei Kobayashi, Mitsuru Ishii, Yoshitaka Goto, Koh Ono, Takeshi Kimura
Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial. Journal of the American Heart Association 13 (15) (2024)
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, Kazunori Otsui, Daisuke Sueta, Yukari Tsubata, Masaaki Shoji, Ayumi Shikama, Yutaka Hosoi, Yasuhiro Tanabe, Kengo Tsukahara, Naohiko Nakanishi, Kitae Kim, Satoshi Ikeda, Kazunori Mushiake, Kazushige Kadota, Koh Ono, Takeshi Kimura
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study. European heart journal. Cardiovascular pharmacotherapy 10 (5) (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Tetsuma Kawaji, Satoshi Shizuta, Hidenori Yaku, Kazuhisa Kaneda, Fumiya Yoneda, Shushi Nishiwaki, Munekazu Tanaka, Takanori Aizawa, Shun Hojo, Kenji Nakatsuma, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, Koh Ono, Takeshi Kimura
Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study. PloS one 19 (8) (2024)
Eri Toda Kato, Koji Hasegawa, Koh Ono
The Impact of SGLT2 Inhibitors in Post-Myocardial Infarction Management: Insights from EMPACT-MI and DAPA-MI Trials. European heart journal. Cardiovascular pharmacotherapy (2024)
Tetsuma Kawaji, Satoshi Shizuta, Hidenori Yaku, Kazuhisa Kaneda, Fumiya Yoneda, Shushi Nishiwaki, Munekazu Tanaka, Takanori Aizawa, Shun Hojo, Kenji Nakatsuma, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, Koh Ono, Takeshi Kimura
Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study. PloS one 19 (8) (2024)
Sijia Xu, Hiroki Shiomi, Yugo Yamashita, Satoshi Koyama, Takahiro Horie, Osamu Baba, Masahiro Kimura, Yasuhiro Nakashima, Naoya Sowa, Koji Hasegawa, Ayako Suzuki, Yutaka Suzuki, Takeshi Kimura, Koh Ono
CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PloS one 19 (3) (2024)
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, Kazunori Otsui, Daisuke Sueta, Yasuhiro Tanabe, Masaaki Shoji, Ayumi Shikama, Yutaka Hosoi, Yasuhiro Tanabe, Kengo Tsukahara, Naohiko Nakanishi, Kitae Kim, Satoshi Ikeda, Kazunori Mushiake, Kazushige Kadota, Koh Ono, Takeshi Kimura
Edoxaban for 12 Versus 3 Months in Cancer-associated Isolated Distal Deep Vein Thrombosis According to Different Doses: Insights from the ONCO DVT study. European heart journal. Cardiovascular pharmacotherapy (2024)
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, Kazunori Otsui, Daisuke Sueta, Yukari Tsubata, Masaaki Shoji, Ayumi Shikama, Yutaka Hosoi, Yasuhiro Tanabe, Kengo Tsukahara, Naohiko Nakanishi, Kitae Kim, Satoshi Ikeda, Kazunori Mushiake, Kazushige Kadota, Koh Ono, Takeshi Kimura
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study. European heart journal. Cardiovascular pharmacotherapy 10 (5) (2024)
Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Hideo Tokuyama, Hiroki Sakamoto, Takanari Fujita, Mamoru Nanasato, Hideki Okayama, Tenjin Nishikura, Hidekuni Kirigaya, Koji Nishida, Koh Ono, Takeshi Kimura
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial. European heart journal. Cardiovascular pharmacotherapy (2024)
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Minoru Yamada, Tetsuzo Wakatsuki, Yoichi Nozaki, Hideki Kitahara, Ryuichi Kato, Ryoma Kawai, Yohei Kobayashi, Mitsuru Ishii, Yoshitaka Goto, Koh Ono, Takeshi Kimura
Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial. Journal of the American Heart Association (2024)
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui, Jiro Sakamoto, Yoshito Ogihara, Takeshi Inoue, Shunsuke Usami, Po-Min Chen, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Kosuke Doi, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Tomohiro Dohke, Ryusuke Nishikawa, Koh Ono, Takeshi Kimura
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era. Journal of the American Heart Association 13 (15) (2024)
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, Kazunori Otsui, Daisuke Sueta, Yukari Tsubata, Masaaki Shoji, Ayumi Shikama, Yutaka Hosoi, Yasuhiro Tanabe, Kengo Tsukahara, Naohiko Nakanishi, Kitae Kim, Satoshi Ikeda, Kazunori Mushiake, Kazushige Kadota, Koh Ono, Takeshi Kimura
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study. European heart journal. Cardiovascular pharmacotherapy 10 (5) (2024)
Shinya Ikeda, Yugo Yamashita, Koh Ono
Who requires longer-term anticoagulation therapy for venous thromboembolism from the perspective of precision medicine? European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Ryusuke Nishikawa, Kenji Ando, Satoru Suwa, Tsuyoshi Isawa, Hiroyuki Takenaka, Tetsuya Ishikawa, Hideo Tokuyama, Hiroki Sakamoto, Takanari Fujita, Mamoru Nanasato, Hideki Okayama, Tenjin Nishikura, Hidekuni Kirigaya, Koji Nishida, Koh Ono, Takeshi Kimura, null null
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial. European heart journal. Cardiovascular pharmacotherapy 10 (5) (2024)
Takahiro Horie, Koh Ono
VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. European heart journal. Cardiovascular pharmacotherapy (2023)
Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Kenji Ando, Takenori Domei, Satoru Suwa, Manabu Ogita, Tsuyoshi Isawa, Hiroyuki Takenaka, Takashi Yamamoto, Tetsuya Ishikawa, Itaru Hisauchi, Kohei Wakabayashi, Yuko Onishi, Kiyoshi Hibi, Kazuya Kawai, Ruka Yoshida, Hiroshi Suzuki, Gaku Sr Nakazawa, Takanori Kusuyama, Itsuro Morishima, Koh Ono, Takeshi Kimura
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Circulation (2023)
Eri Toda Kato, Koh Ono, Basil S Lewis
SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from AHA. European heart journal. Cardiovascular pharmacotherapy (2023)
Sawa Miyagawa, Takahiro Horie, Tomohiro Nishino, Satoshi Koyama, Toshimitsu Watanabe, Osamu Baba, Tomohiro Yamasaki, Naoya Sowa, Chiharu Otani, Kazuki Matsushita, Hidenori Kojima, Masahiro Kimura, Yasuhiro Nakashima, Satoshi Obika, Yusuke Tamenori, Jun Kotera, Kozo Oka, Ryo Fujita, Takashi Sasaki, Akihiro Takemiya, Koji Hasegawa, Takeshi Kimura, Koh Ono
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis. Life science alliance 6 (8) (2023)
Takahiro Horie, Tetsushi Nakao, Yui Miyasaka, Tomohiro Nishino, Shigenobu Matsumura, Fumiko Nakazeki, Yuya Ide, Masahiro Kimura, Shuhei Tsuji, Randolph Ruiz Rodriguez, Toshimitsu Watanabe, Tomohiro Yamasaki, Sijia Xu, Chiharu Otani, Sawa Miyagawa, Kazuki Matsushita, Naoya Sowa, Aoi Omori, Jin Tanaka, Chika Nishimura, Masataka Nishiga, Yasuhide Kuwabara, Osamu Baba, Shin Watanabe, Hitoo Nishi, Yasuhiro Nakashima, Marina R Picciotto, Haruhisa Inoue, Dai Watanabe, Kazuhiro Nakamura, Tsutomu Sasaki, Takeshi Kimura, Koh Ono
microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity. Nature communications 12 (1) (2021)
Koh Ono, Hiromichi Wada, Noriko Satoh-Asahara, Hitoki Inoue, Keita Uehara, Junichi Funada, Atsushi Ogo, Takahiro Horie, Masatoshi Fujita, Akira Shimatsu, Koji Hasegawa, null null
Effects of Metformin on Left Ventricular Size and Function in Hypertensive Patients with Type 2 Diabetes Mellitus: Results of a Randomized, Controlled, Multicenter, Phase IV Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 20 (3) (2021)
Koh Ono, Takahiro Horie, Osamu Baba, Masahiro Kimura, Shuhei Tsuji, Randolph Ruiz Rodriguez, Sawa Miyagawa, Takeshi Kimura
Functional non-coding RNAs in vascular diseases. The FEBS journal 288 (22) (2021)
Kazuki Nakamura, Ryosuke Kojima, Eiichiro Uchino, Koh Ono, Motoko Yanagita, Koichi Murashita, Ken Itoh, Shigeyuki Nakaji, Yasushi Okuno
Health improvement framework for actionable treatment planning using a surrogate Bayesian model. Nature communications 12 (1) (2021)
Yasuhide Kuwabara, Shuhei Tsuji, Masataka Nishiga, Masayasu Izuhara, Shinji Ito, Kazuya Nagao, Takahiro Horie, Shin Watanabe, Satoshi Koyama, Hisanori Kiryu, Yasuhiro Nakashima, Osamu Baba, Tetsushi Nakao, Tomohiro Nishino, Naoya Sowa, Yui Miyasaka, Takeshi Hatani, Yuya Ide, Fumiko Nakazeki, Masahiro Kimura, Yoshinori Yoshida, Tsukasa Inada, Takeshi Kimura, Koh Ono
Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload. Communications biology 3 (1) (2020)
Masahiro Kimura, Takahiro Horie, Osamu Baba, Yuya Ide, Shuhei Tsuji, Randolph Ruiz Rodriguez, Toshimitsu Watanabe, Tomohiro Yamasaki, Chiharu Otani, Sijia Xu, Yui Miyasaka, Yasuhiro Nakashima, Takeshi Kimura, Koh Ono
Homeobox A4 suppresses vascular remodeling by repressing YAP/TEAD transcriptional activity. EMBO reports 21 (4) (2020)
Fumiko Nakazeki, Itaru Tsuge, Takahiro Horie, Keiko Imamura, Kayoko Tsukita, Akitsu Hotta, Osamu Baba, Yasuhide Kuwabara, Tomohiro Nishino, Tetsushi Nakao, Masataka Nishiga, Hitoo Nishi, Yasuhiro Nakashima, Yuya Ide, Satoshi Koyama, Masahiro Kimura, Shuhei Tsuji, Motoko Naitoh, Shigehiko Suzuki, Yuishin Izumi, Toshitaka Kawarai, Ryuji Kaji, Takeshi Kimura, Haruhisa Inoue, Koh Ono
MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons. Clinical science (London, England : 1979) 133 (4) (2019)
Jaekwang Kim, Hyejin Yoon, Takahiro Horie, Jack M Burchett, Jessica L Restivo, Noemi Rotllan, Cristina M Ramírez, Philip B Verghese, Masafumi Ihara, Hyang-Sook Hoe, Christine Esau, Carlos Fernández-Hernando, David M Holtzman, John R Cirrito, Koh Ono, Jungsu Kim
microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain. The Journal of neuroscience : the official journal of the Society for Neuroscience 35 (44) (2016)